Arkolith/Insider Trading/RIGL/Form 4

Santos David A

EVP, Chief Commercial OfficerRIGEL PHARMACEUTICALS INC (RIGL) · full profile →Form 4 · filed Sep 17, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 15, 2025Grant(A)7K—$07K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-003350) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML